Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Resources
Science Hub
Press releases
News
Events
Media kit
Services
Process Development
Analytics
Drug Substance Manufacturing
Contact
Contact form
Contact for investors
Contact for media
Careers
Science News
Resources
Drug development
Oncologic Bispecific Antibodies in Immunotherapy
Biologics
,
Bispecific antibody
,
Cancer
,
Drug development
Bioprocess Optimization Across Upstream and Downstream Processing
Drug development
,
Drug product
,
Drug substance
,
Manufacturing
Tailoring Cell Line Development for Efficient Biologics Process Outcomes
Biologics
,
Drug development
,
GMP
,
Manufacturing
Challenges and Solutions in ADC Development for Biologic Therapeutics
Antibody-drug conjugates
,
Biologics
,
Drug development
GMP Biologics Manufacturing in End-to-End Drug Development
Biologics
,
Drug development
,
GMP
,
Manufacturing
5 Analytical Challenges in Biosimilar Characterization and Comparability
Biologics
,
Drug development
Poster
Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency
Biologics
,
Drug development
,
Mabion
,
Manufacturing
The Role of High-Throughput Screening (HTS) in Cell Line Development and Process Optimization
Biologics
,
Drug development
Co-Development Partnership Models in Biologics Programs
Biologics
,
Drug development
,
Mabion
,
Partnership
1
2
3
Next